Person · CIK 1741987

Patrick Burnett

EVP at Arcutis Biotherapeutics

Earlier: Verrica Pharmaceuticals

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$5.9M

Noticed on Form 144$5.3M

Bought on Form 4$0

Companies2

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Arcutis Biotherapeutics ARQT	Common Stock	Directly	116,649	Nov 2, 2026 · Filing · EDGAR
Arcutis Biotherapeutics ARQT	Stock Option (right to buy) exercise $3.64, expires Jan 12, 2034, into Common Stock	Directly	128,750	Aug 12, 2026 · Filing · EDGAR
Verrica Pharmaceuticals	Employee Stock Option (Right to Buy) exercise $11.81, expires Feb 26, 2030, into Common Stock	Directly	55,000	Feb 27, 2020 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)
Q4 2026	$30K	Not machine-readable
Q3 2026	$466K	Not machine-readable
Q2 2026	$21K	Not machine-readable
Q1 2026	$577K	$577K
Q4 2025	$956K	$956K
Q3 2025	$591K	$590K
Q2 2025	$92K	$92K
Q1 2025	$1.1M	$1.1M
Q4 2024	$1M	$1M
Q3 2024	$133K	$133K
Q2 2024	$720K	$720K
Q1 2024	$58K	$58K
Q3 2023	$11K	$11K
Q1 2023	$63K	Not machine-readable
Q1 2022	$17K	Not machine-readable

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Arcutis Biotherapeutics ARQT · Merrill Lynch · No 10b5-1 plan stated · 14 notices
Mar 2, 2026	6,287 · ~$158K	Mar 2, 2026	Sold as noticed Sold 6,287 in 2 sales, Mar 2 to Mar 2 · $158K Form 4	Filing · EDGAR
Feb 2, 2026	3,675 · ~$94K	Feb 2, 2026	Sold as noticed Sold 3,675 at $25.50 on Feb 2 · $94K Form 4	Filing · EDGAR
Dec 31, 2025	1,697 · ~$50K	Dec 31, 2025	Sold as noticed Sold 1,697 in 2 sales, Dec 31 to Dec 31 · $50K Form 4	Filing · EDGAR
Nov 3, 2025	2,622 · ~$65K	Nov 3, 2025	Sold as noticed Sold 2,607 at $24.71 on Nov 3 · $64K Form 4	Filing · EDGAR
Aug 19, 2025	1,750 · ~$28K	Aug 19, 2025	Not sold within 90 days	Filing · EDGAR
Aug 4, 2025	2,622 · ~$38K	Aug 4, 2025	Partly sold Sold 1,750 at $16.16 on Aug 19 · $28K likely match Form 4	Filing · EDGAR
May 2, 2025	2,597 · ~$39K	May 2, 2025	Not sold within 90 days	Filing · EDGAR
Mar 3, 2025	954 · ~$13K	Mar 4, 2025	Not sold within 90 days	Filing · EDGAR
Mar 3, 2025	2,819 · ~$37K	Mar 3, 2025	Sold as noticed Sold 2,819 at $13.03 on Mar 3 · $37K Form 4	Filing · EDGAR
Feb 3, 2025	12,116 · ~$154K	Feb 3, 2025	Sold as noticed Sold 12,116 at $12.70 on Feb 3 · $154K Form 4	Filing · EDGAR
Dec 31, 2024	1,691 · ~$24K	Dec 31, 2024	Sold as noticed Sold 1,691 at $14.00 on Dec 31 · $24K Form 4	Filing · EDGAR
Nov 22, 2024	16,023 · ~$163K	Nov 22, 2024	Sold as noticed Sold 16,023 at $10.14 on Nov 22 · $163K Form 4	Filing · EDGAR
Nov 15, 2024	100 · ~$1K	Nov 15, 2024	Not sold within 90 days	Filing · EDGAR
Nov 14, 2024	69,126 · ~$712K	Nov 14, 2024	Sold as noticed Sold 69,126 in 2 sales, Nov 14 to Nov 14 · $712K Form 4	Filing · EDGAR
Arcutis Biotherapeutics ARQT · Merrill Lynch · 10b5-1 plan adopted Dec 12, 2024 · 12 notices
Feb 4, 2026	9,794 · ~$253K	Feb 4, 2026	Sold as noticed Sold 9,794 at $25.81 on Feb 4 · $253K Form 4	Filing · EDGAR
Jan 5, 2026	2,490 · ~$72K	Jan 5, 2026	Sold as noticed Sold 2,490 at $28.98 on Jan 5 · $72K Form 4	Filing · EDGAR
Dec 15, 2025	11,500 · ~$333K	Dec 15, 2025	Sold as noticed Sold 11,500 at $28.94 on Dec 15 · $333K Form 4	Filing · EDGAR
Nov 6, 2025	17,250 · ~$417K	Nov 6, 2025	Sold as noticed Sold 17,250 at $24.18 on Nov 6 · $417K Form 4	Filing · EDGAR
Nov 5, 2025	3,846 · ~$91K	Nov 5, 2025	Sold as noticed Sold 3,864 at $23.72 on Nov 5 · $92K Form 4	Filing · EDGAR
Aug 21, 2025	2,438 · ~$38K	Aug 21, 2025	Sold as noticed Sold 2,438 at $15.57 on Aug 21 · $38K Form 4	Filing · EDGAR
Aug 8, 2025	3,847 · ~$54K	Aug 8, 2025	Sold as noticed Sold 3,862 in 2 sales, Aug 8 to Nov 3 · $54K Form 4 (1) · Form 4 (2)	Filing · EDGAR
Jul 14, 2025	5,750 · ~$87K	Jul 14, 2025	Sold as noticed Sold 5,750 at $15.07 on Jul 14 · $87K Form 4	Filing · EDGAR
Jul 10, 2025	23,000 · ~$346K	Jul 10, 2025	Sold as noticed Sold 23,000 at $15.05 on Jul 10 · $346K Form 4	Filing · EDGAR
May 8, 2025	3,871 · ~$53K	May 8, 2025	Partly sold Sold 2,622 at $14.33 on Aug 4 · $38K likely match Form 4	Filing · EDGAR
Mar 14, 2025	12,242 · ~$184K	Mar 4, 2025	Partly sold Sold 8,879 in 2 sales, Mar 13 to May 8 · $128K likely match Form 4 (1) · Form 4 (2)	Filing · EDGAR
Mar 13, 2025	49,161 · ~$736K	Mar 4, 2025	Partly sold Sold 47,704 in 3 sales, Mar 4 to May 2 · $713K likely match Form 4 (1) · Form 4 (2) · Form 4 (3)	Filing · EDGAR
Arcutis Biotherapeutics ARQT · Merrill · No 10b5-1 plan stated · 9 notices
Nov 4, 2024	15,441 · ~$134K	Nov 4, 2024	Sold as noticed Sold 15,441 at $8.68 on Nov 4 · $134K Form 4	Filing · EDGAR
Aug 19, 2024	1,728 · ~$14K	Aug 19, 2024	Partly sold Sold 100 at $10.03 on Nov 15 · $1K likely match Form 4	Filing · EDGAR
Aug 2, 2024	13,026 · ~$119K	Aug 1, 2024	Partly sold Sold 1,728 at $8.29 on Aug 19 · $14K likely match Form 4	Filing · EDGAR
May 30, 2024	23,000 · ~$201K	May 30, 2024	Sold as noticed Sold 23,000 at $8.75 on May 30 · $201K Form 4	Filing · EDGAR
May 29, 2024	49,952 · ~$435K	May 29, 2024	Sold as noticed Sold 49,952 at $8.72 on May 29 · $435K Form 4	Filing · EDGAR
May 2, 2024	9,555 · ~$83K	May 2, 2024	Sold as noticed Sold 9,555 at $8.74 on May 2 · $83K Form 4	Filing · EDGAR
Mar 4, 2024	4,782 · ~$53K	Mar 4, 2024	Sold as noticed Sold 4,782 at $11.12 on Mar 4 · $53K Form 4	Filing · EDGAR
Jan 2, 2024	1,325 · ~$5K	Jan 2, 2024	Sold as noticed Sold 1,325 at $3.54 on Jan 2 · $5K Form 4	Filing · EDGAR
Aug 21, 2023	1,605 · ~$11K	Aug 21, 2023	Sold as noticed Sold 1,605 in 2 sales, Aug 21 to Aug 21 · $11K Form 4	Filing · EDGAR
Sales without a matching Form 144 · 15 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Sold without notice Arcutis Biotherapeutics (ARQT): Sold 943 at $31.86 on Nov 2, 2026 · $30K	Filing · EDGAR
—	—	—	Sold without notice Arcutis Biotherapeutics (ARQT): Sold 1,697 at $27.00 on Aug 19, 2026 · $46K	Filing · EDGAR
—	—	—	Sold without notice Arcutis Biotherapeutics (ARQT): Sold 6,700 at $26.08 on Aug 12, 2026 · $175K	Filing · EDGAR
—	—	—	Sold without notice Arcutis Biotherapeutics (ARQT): Sold 8,300 at $26.52 on Aug 11, 2026 · $220K	Filing · EDGAR
—	—	—	Sold without notice Arcutis Biotherapeutics (ARQT): Sold 955 at $26.12 on Aug 3, 2026 · $25K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Arcutis Biotherapeutics (ARQT): Sold 222 at $21.05 on May 11, 2026 · $5K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Arcutis Biotherapeutics (ARQT): Sold 684 at $23.61 on May 4, 2026 · $16K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Arcutis Biotherapeutics (ARQT): Sold 12,242 at $15.04 on Mar 14, 2025 · $184K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Arcutis Biotherapeutics (ARQT): Sold 13,206 at $9.02 on Aug 2, 2024 · $119K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 851 at $15.26 on Mar 6, 2023 · $13K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 23 at $16.52 on Mar 2, 2023 · $380 (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 1,728 at $15.82 on Mar 2, 2023 · $27K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 1,475 at $15.01 on Jan 3, 2023 · $22K	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 30 at $16.44 on Mar 7, 2022 · $493 (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 981 at $16.86 on Mar 4, 2022 · $17K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Arcutis Biotherapeutics ARQT EVP, Chief Medical Officer · filings 2020 to 2026 · sold $5.9M · $5.3M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Nov 2, 2026	Open-market or private sale	−943	$31.86	$30K	116,649 direct	Filing · EDGAR
Aug 19, 2026	Open-market or private sale	−1,697	$27.00	$46K	117,592 direct	Filing · EDGAR
Aug 12, 2026	Option or RSU exercised or converted	+6,700	$3.64	$24K	125,989 direct	Filing · EDGAR
Aug 12, 2026	Open-market or private sale	−6,700	$26.08	$175K	119,289 direct	Filing · EDGAR
Aug 12, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−6,700			128,750 direct	Filing · EDGAR
Aug 11, 2026	Option or RSU exercised or converted	+8,300	$3.64	$30K	127,589 direct	Filing · EDGAR
Aug 11, 2026	Open-market or private sale	−8,300	$26.52	$220K	119,289 direct	Filing · EDGAR
Aug 11, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−8,300			135,450 direct	Filing · EDGAR
Aug 3, 2026	Sale under a 10b5-1 plan	−955	$26.12	$25K	119,289 direct	Filing · EDGAR
May 11, 2026	Sale under a 10b5-1 plan	−222	$21.05	$5K	120,244 direct	Filing · EDGAR
May 4, 2026	Sale under a 10b5-1 plan	−684	$23.61	$16K	120,466 direct	Filing · EDGAR
Mar 2, 2026	Sale under a 10b5-1 plan	−6,106	$25.16	$154K	121,295 direct	Filing · EDGAR
Mar 2, 2026	Sale under a 10b5-1 plan	−181	$25.91	$5K	121,150 direct	Filing · EDGAR
Feb 27, 2026	Grant or award from the company	+30,000			127,401 direct	Filing · EDGAR
Feb 27, 2026	Grant or award from the company Stock Option (right to buy)	+77,000			77,000 direct	Filing · EDGAR
Feb 4, 2026	Sale under a 10b5-1 plan	−9,794	$25.81	$253K	80,651 direct	Filing · EDGAR
Feb 2, 2026	Sale under a 10b5-1 plan	−3,675	$25.50	$94K	90,445 direct	Filing · EDGAR
Jan 5, 2026	Sale under a 10b5-1 plan	−2,490	$28.98	$72K	94,120 direct	Filing · EDGAR
Dec 31, 2025	Sale under a 10b5-1 plan	−541	$28.81	$16K	97,766 direct	Filing · EDGAR
Dec 31, 2025	Sale under a 10b5-1 plan	−1,156	$29.39	$34K	96,610 direct	Filing · EDGAR
Dec 15, 2025	Option or RSU exercised or converted	+11,500	$3.64	$42K	109,807 direct	Filing · EDGAR
Dec 15, 2025	Sale under a 10b5-1 plan	−11,500	$28.94	$333K	98,307 direct	Filing · EDGAR
Dec 15, 2025	Option or RSU exercised or converted Stock Option (right to buy)	−11,500			143,750 direct	Filing · EDGAR
Nov 6, 2025	Option or RSU exercised or converted	+17,250	$3.64	$63K	115,575 direct	Filing · EDGAR
Nov 6, 2025	Sale under a 10b5-1 plan	−17,250	$24.18	$417K	98,325 direct	Filing · EDGAR
Nov 6, 2025	Option or RSU exercised or converted Stock Option (right to buy)	−17,250			155,250 direct	Filing · EDGAR
Nov 5, 2025	Sale under a 10b5-1 plan	−3,864	$23.72	$92K	98,325 direct	Filing · EDGAR
Nov 3, 2025	Sale under a 10b5-1 plan	−2,607	$24.71	$64K	102,204 direct	Filing · EDGAR
Nov 3, 2025	Sale under a 10b5-1 plan	−15	$25.40	$381	102,189 direct	Filing · EDGAR
Aug 21, 2025	Sale under a 10b5-1 plan	−2,438	$15.57	$38K	104,811 direct	Filing · EDGAR
Aug 19, 2025	Sale under a 10b5-1 plan	−1,750	$16.16	$28K	107,249 direct	Filing · EDGAR
Aug 8, 2025	Sale under a 10b5-1 plan	−3,847	$14.03	$54K	108,999 direct	Filing · EDGAR
Aug 4, 2025	Sale under a 10b5-1 plan	−2,622	$14.33	$38K	112,846 direct	Filing · EDGAR
Jul 14, 2025	Option or RSU exercised or converted	+5,750			121,218 direct	Filing · EDGAR
Jul 14, 2025	Sale under a 10b5-1 plan	−5,750	$15.07	$87K	115,468 direct	Filing · EDGAR
Jul 14, 2025	Option or RSU exercised or converted Stock Option (right to buy)	−5,750			172,500 direct	Filing · EDGAR
Jul 10, 2025	Option or RSU exercised or converted	+23,000			138,468 direct	Filing · EDGAR
Jul 10, 2025	Sale under a 10b5-1 plan	−23,000	$15.05	$346K	115,468 direct	Filing · EDGAR
Jul 10, 2025	Option or RSU exercised or converted Stock Option (right to buy)	−23,000			178,250 direct	Filing · EDGAR
May 8, 2025	Sale under a 10b5-1 plan	−3,871	$13.59	$53K	115,468 direct	Filing · EDGAR
May 2, 2025	Sale under a 10b5-1 plan	−2,597	$15.19	$39K	119,339 direct	Filing · EDGAR
Mar 14, 2025	Option or RSU exercised or converted	+12,242			134,178 direct	Filing · EDGAR
Mar 14, 2025	Sale under a 10b5-1 plan	−12,242	$15.04	$184K	121,936 direct	Filing · EDGAR
Mar 14, 2025	Option or RSU exercised or converted Stock Option (right to buy)	−12,242			201,250 direct	Filing · EDGAR
Mar 13, 2025	Sale under a 10b5-1 plan	−44,153	$14.97	$661K	121,936 direct	Filing · EDGAR
Mar 13, 2025	Option or RSU exercised or converted	+5,008			126,944 direct	Filing · EDGAR
Mar 13, 2025	Sale under a 10b5-1 plan	−5,008	$15.10	$76K	121,936 direct	Filing · EDGAR
Mar 13, 2025	Option or RSU exercised or converted Stock Option (right to buy)	−5,008			213,492 direct	Filing · EDGAR
Mar 4, 2025	Sale under a 10b5-1 plan	−954	$13.28	$13K	166,089 direct	Filing · EDGAR
Mar 3, 2025	Sale under a 10b5-1 plan	−2,819	$13.03	$37K	167,043 direct	Filing · EDGAR
Feb 28, 2025	Grant or award from the company	+38,000			152,862 direct	Filing · EDGAR
Feb 28, 2025	Grant or award from the company	+17,000			169,862 direct	Filing · EDGAR
Feb 28, 2025	Grant or award from the company Stock Option (right to buy)	+99,000			99,000 direct	Filing · EDGAR
Feb 28, 2025	Grant or award from the company Stock Option (right to buy)	+43,000			43,000 direct	Filing · EDGAR
Feb 3, 2025	Sale under a 10b5-1 plan	−12,116	$12.70	$154K	114,862 direct	Filing · EDGAR
Dec 31, 2024	Sale under a 10b5-1 plan	−1,691	$14.00	$24K	126,978 direct	Filing · EDGAR
Nov 22, 2024	Option or RSU exercised or converted	+16,023			144,692 direct	Filing · EDGAR
Nov 22, 2024	Open-market or private sale	−16,023	$10.14	$163K	128,669 direct	Filing · EDGAR
Nov 22, 2024	Option or RSU exercised or converted Stock Option (right to buy)	−16,023			218,500 direct	Filing · EDGAR
Nov 15, 2024	Option or RSU exercised or converted	+100			128,769 direct	Filing · EDGAR

44 earlier transactions are in the filing list below.

Verrica Pharmaceuticals Chief Medical Officer · filings 2018 to 2020

Date	Transaction	Shares	Price	Value	Held after	Source
Feb 27, 2020	Grant or award from the company Employee Stock Option (Right to Buy)	+55,000			55,000 direct	Filing · EDGAR
Feb 28, 2019	Grant or award from the company Employee Stock Option (Right to Buy)	+52,508			52,508 direct	Filing · EDGAR

All 87 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Nov 4, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 2, 2026	Form 144	Could not read	EDGAR
Aug 21, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 19, 2026	Form 144	Could not read	EDGAR
Aug 13, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 11, 2026	Form 144	Could not read	EDGAR
Aug 5, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 3, 2026	Form 144	Could not read	EDGAR
May 13, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 11, 2026	Form 144	Could not read	EDGAR
May 6, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 4, 2026	Form 144	Could not read	EDGAR
Mar 3, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 2, 2026	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Feb 4, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Feb 4, 2026	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Feb 2, 2026	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 7, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 5, 2026	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 2, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Dec 31, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Dec 17, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Dec 15, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 10, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 6, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 5, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 5, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 3, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 21, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 21, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 19, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 12, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 8, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 5, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 4, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jul 14, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jul 14, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jul 10, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 9, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 8, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 5, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 2, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 17, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 14, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 13, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 4, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 4, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 3, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Feb 4, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Feb 3, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Dec 31, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Dec 31, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 26, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 22, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 18, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 15, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 14, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 5, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 4, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 21, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 19, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 5, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 2, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 31, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 30, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 29, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 3, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 2, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 6, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 4, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Feb 15, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 17, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 3, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 2, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 22, 2023	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 21, 2023	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 8, 2023	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 6, 2023	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 4, 2023	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 7, 2022	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 4, 2022	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 5, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 5, 2020	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 5, 2020	Form 3	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 2, 2020	Form 4	Verrica Pharmaceuticals	Filing · EDGAR
Mar 4, 2019	Form 4	Verrica Pharmaceuticals	Filing · EDGAR
Jun 14, 2018	Form 3	Verrica Pharmaceuticals	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 5, 2026, 10:48 PM ET. The filing on SEC.gov is the record.